Eagle LogoPEPTIDE INITIATIVE

Peptide Database

Goals
Fat LossMuscle BuildingInjury HealingAnti-AgingCognitive EnhancementSleep OptimizationImmune SupportGut HealingSkin RejuvenationSexual Health
Peptides
Adipotide
Weight Management
AOD-9604
Weight Management
BPC-157
Healing & Recovery
Cagrilintide
Weight Management
CJC-1295
Growth Hormone
DSIP
Sleep & Recovery
Epithalon
Anti-Aging
GHK-Cu
Anti-Aging
GHRP-2
Growth Hormone
HCG
Hormone Support
Hexarelin
Growth Hormone
HGH
Growth Hormone
IGF-1 LR3
Growth Hormone
Kisspeptin
Hormone Support
Melanotan-2
Cosmetic
MOTS-C
Metabolic
NAD+
Anti-Aging
Oxytocin Acetate
Hormone Support
PEG-MGF
Recovery
PNC-27
Cancer Research
PT-141
Sexual Health
Retatrutide
Weight Management
Selank
Cognitive
Semaglutide
Weight Management
Semax
Cognitive
Sermorelin
Growth Hormone
Snap-8
Cosmetic
SS-31
Mitochondrial
TB-500
Healing & Recovery
Tesamorelin
Growth Hormone
Thymosin Alpha-1
Immune
Tirzepatide
Weight Management
Total Peptides: 32
Back to Home

Peptide Comparison

Pralmorelin (GHRP-2)vsGHRP-6 (Growth Hormone Releasing Peptide-6)

A powerful hexapeptide that stimulates growth hormone release—used clinically in Japan for GH testing and studied for healing and anti-inflammatory effects.

A synthetic hexapeptide that signals your pituitary to release growth hormone through a unique pathway, with emerging evidence of heart-protective benefits.

Growth HormoneGrowth Hormone

At a Glance

Quick
comparison

Dose Range

Pralmorelin (GHRP-2)

100–300 mcg

GHRP-6 (Growth Hormone Releasing Peptide-6)

100–300 mcg

Frequency

Pralmorelin (GHRP-2)

Once daily

GHRP-6 (Growth Hormone Releasing Peptide-6)

Multiple times daily

Administration

Pralmorelin (GHRP-2)

Subcutaneous injection

GHRP-6 (Growth Hormone Releasing Peptide-6)

Subcutaneous injection

Cycle Length

Pralmorelin (GHRP-2)

4-6 weeks

GHRP-6 (Growth Hormone Releasing Peptide-6)

8-12 weeks

Onset Speed

Pralmorelin (GHRP-2)

Rapid (hours to days)

GHRP-6 (Growth Hormone Releasing Peptide-6)

Moderate (1-2 weeks)

Evidence Level

Pralmorelin (GHRP-2)

Limited human trials

GHRP-6 (Growth Hormone Releasing Peptide-6)

Limited human trials

Efficacy

Benefit
ratings

Pralmorelin (GHRP-2)
GHRP-6 (Growth Hormone Releasing Peptide-6)

Muscle & Performance Enhancement

Pralmorelin (GHRP-2)90%
GHRP-6 (Growth Hormone Releasing Peptide-6)0%

Injury Recovery & Healing

Pralmorelin (GHRP-2)85%
GHRP-6 (Growth Hormone Releasing Peptide-6)0%

Diagnostic Clinical Use

Pralmorelin (GHRP-2)95%
GHRP-6 (Growth Hormone Releasing Peptide-6)0%

Muscle Recovery and Growth

Pralmorelin (GHRP-2)0%
GHRP-6 (Growth Hormone Releasing Peptide-6)85%

Cellular Health and Protection

Pralmorelin (GHRP-2)0%
GHRP-6 (Growth Hormone Releasing Peptide-6)72%

Appetite and Nutrient Intake

Pralmorelin (GHRP-2)0%
GHRP-6 (Growth Hormone Releasing Peptide-6)88%

Technical Data

Compound
specifications

Pralmorelin (GHRP-2)

Molecular Formula

C45H55N9O6

Molecular Weight

818.0 g/mol

Half-Life

15-60 minutes

Bioavailability

~100% (subcutaneous injection)

CAS Number

158861-67-7

GHRP-6 (Growth Hormone Releasing Peptide-6)

Molecular Formula

C46H56N12O6

Molecular Weight

873.0 g/mol

Half-Life

~2.5 hours

Bioavailability

<1% oral, high subcutaneous

CAS Number

87616-84-0

Protocols

Dosing
tiers

Pralmorelin (GHRP-2)

starting

50-100 mcg

Once daily or twice weekly

1-2 weeks

Begin conservatively to assess individual responsiveness and side effect tolerance. Administer subcutaneously in abdomen or thigh.

standard

100-200 mcg

1-3 times daily

4-6 weeks

Most individuals find optimal response and tolerability in this range. Typical use case for GH axis stimulation and recovery support.

advanced

200-300 mcg

2-3 times daily

4-8 weeks

Higher doses used in intensive research or competitive athletic settings. Requires previous GHRP experience and close monitoring. Risk-benefit ratio increases.

GHRP-6 (Growth Hormone Releasing Peptide-6)

starting

100 mcg per injection

1-2 times daily (morning and/or evening)

2-4 weeks

Begin with once-daily dosing to assess tolerance and individual response. Many users start with an evening injection to take advantage of natural nighttime GH pulses.

standard

150-200 mcg per injection

2-3 times daily (morning, afternoon, evening)

6-8 weeks

Most users find this range effective for sustained GH stimulation. Timing around workouts can maximize the anabolic response. Some space injections 4-6 hours apart.

advanced

250-300 mcg per injection

3+ times daily

8-12 weeks

Only for experienced users with good tolerance established. Higher frequency can lead to receptor desensitization, so cycling (e.g., 5 days on, 2 days off) may preserve effectiveness. Requires careful monitoring.

Applications

Best
suited for

Pralmorelin (GHRP-2)

Athletes and Fitness Enthusiasts

If you're serious about lean muscle gains and recovery, pralmorelin directly stimulates GH release—one of the body's most powerful anabolic hormones. Most athletes in research settings use 100-200 mcg for faster muscle repair and improved performance.

Individuals Recovering from Injury

Recent animal studies show GHRP-2 reduces inflammation and speeds tendon-bone healing. If you're dealing with sports injuries, rotator cuff issues, or fractures, this peptide's anti-inflammatory profile may accelerate recovery when combined with proper rehab.

Those Seeking Diagnostic GH Testing

If your doctor suspects growth hormone deficiency, pralmorelin is the gold-standard diagnostic tool in Japan and many countries. A single injection stimulates GH release, allowing physicians to assess your pituitary function safely and accurately.

Peptide Research Enthusiasts

Pralmorelin is one of the most extensively studied GHRPs worldwide. If you're exploring peptide protocols and understand research-grade products, this is a powerful tool for understanding how your GH axis responds to stimulation.

GHRP-6 (Growth Hormone Releasing Peptide-6)

Athletes and Serious Trainers

If you're hitting the gym hard and want better recovery and muscle growth, GHRP-6 amplifies your body's natural GH response. This is particularly valuable during intense training phases when you want to maximize adaptation and minimize soreness. The appetite stimulation also helps you consume the calories you need to grow.

Those Exploring Novel Peptide Protocols

GHRP-6 offers a unique mechanism through the ghrelin receptor, making it valuable for users who want to explore diverse GH-stimulation pathways. It works distinctly from GHRH-based approaches and pairs well with other GH secretagogues for synergistic effects.

Longevity and Metabolic Health Enthusiasts

Growth hormone plays roles in metabolic health, body composition, and potentially aging markers. GHRP-6's emerging research on cellular protection and antioxidant activation makes it interesting for those interested in broader health optimization beyond just muscle growth.

Safety Profile

Side
effects

Pralmorelin (GHRP-2)

Common

  • Facial flushing
  • Transient headache
  • Increased appetite
  • Temporary dizziness or lightheadedness

Uncommon

  • Carpal tunnel-like sensations
  • Joint or muscle aches
  • Sleep quality changes

Serious

  • Severe allergic reaction (anaphylaxis)

GHRP-6 (Growth Hormone Releasing Peptide-6)

Common

  • Increased Appetite
  • Mild Joint or Muscle Discomfort
  • Water Retention or Mild Swelling

Uncommon

  • Sleep Disturbances
  • Mild Dizziness or Lightheadedness

Serious

  • Allergic Reaction

Research Status

Safety
& evidence

Pralmorelin (GHRP-2)

Evidence Level

Limited human trials

FDA Status

Research compound

Safety Overview

Pralmorelin (GHRP-2) has been safely used in diagnostic settings in Japan for decades and is well-tolerated in most individuals when used at appropriate doses. The peptide is synthetic and chemically stable, with low immunogenicity risk. However, it is NOT FDA approved and should only be used under medical supervision or within research protocols. Long-term safety data in healthy humans is limited.

Contraindications

  • xActive malignancy or unresolved cancer history
  • xUncontrolled hypertension or severe cardiovascular disease
  • xPregnancy or breastfeeding
  • xAcute infection or sepsis
  • xUncontrolled diabetes

GHRP-6 (Growth Hormone Releasing Peptide-6)

Evidence Level

Limited human trials

FDA Status

Research compound

Safety Overview

GHRP-6 has a relatively long research history dating back to 1981, with human studies demonstrating its ability to stimulate GH release. The good news is that animal safety studies show excellent tolerability at high doses, and the side effects reported are generally mild and reversible. However, it's not FDA-approved, so use is based on research evidence rather than pharmaceutical oversight. Always purchase from reputable sources and consider medical consultation, especially if you have existing health conditions.

Contraindications

  • xKnown allergy or sensitivity to any component of the peptide
  • xActive cancer or history of cancer without medical clearance
  • xSevere cardiovascular disease or uncontrolled hypertension
  • xAcute critical illness or sepsis

Decision Guide

Which is
right for you?

Choose Pralmorelin (GHRP-2) if...

  • Athletes seeking enhanced recovery and lean mass gains
  • Individuals with suspected GH deficiency (diagnostic use)
  • Recovery from tendon or bone injuries
  • Those wanting to test GH axis responsiveness

Choose GHRP-6 (Growth Hormone Releasing Peptide-6) if...

  • Building lean muscle mass and improving body composition
  • Recovery from intense training programs and athletic performance
  • Supporting overall metabolic health and longevity markers
  • Exploring novel GH-stimulation pathways for those who respond well to peptide protocols